Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03923920 · ClinicalTrials.gov registry record
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
A clinical trial of Amyloidosis and Spinal Stenosis, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03923920 is a study of Amyloidosis and Spinal Stenosis that has completed, run by The Cleveland Clinic. The registered enrollment target is 200 participants, below the 1,122-participant average among 28 other Amyloidosis trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03923920, a study of Amyloidosis and Spinal Stenosis, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will prospectively evaluate for the presence of amyloid deposits in ligamentum flavum (yellow ligament) tissue samples obtained from patients undergoing spinal stenosis surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.
Conditions Studied
Interventions
- PROCEDURE Biopsy
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-12-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03923920
The ClinicalTrials.gov registry entry for NCT03923920 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,122-participant average among 28 other Amyloidosis trials with a reported enrollment target (82% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Amyloidosis appearing as the primary indexed condition, and to 1 intervention - of which Biopsy is the first listed.
NCT03923920 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03923920 about?
NCT03923920 is a clinical study titled "Screening for Systemic Amyloidosis Via the Ligamentum Flavum". The investigators will prospectively evaluate for the presence of amyloid deposits in ligamentum flavum (yellow ligament) tissue samples obtained from patients undergoing spinal stenosis surgery. Patients who have tissue that stains positive for amyloid will be referred to an amyloidosis specialist.
What is the current status of trial NCT03923920?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-05-01. Estimated completion is 2021-12-02.
What conditions does trial NCT03923920 study?
This clinical trial studies the following conditions: Amyloidosis, Spinal Stenosis, Transthyretin Amyloidosis, Amyloid, Primary Amyloidosis of Light Chain Type.
What interventions are being tested in trial NCT03923920?
The interventions under investigation include: Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03923920?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03923920 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyloidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RECRUITING · Phase 2
-
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
RECRUITING
-
A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
RECRUITING
-
Dietary Reporting in the Amyloidoses
RECRUITING · NA
-
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RECRUITING · Phase 1
-
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.